ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

U.S. Adults close to Eating “5 A Day” Of Fruits, Vegetables

March 28, 1997

In Brief: AMA Issues Guidelines For HIV Infection, Smoking Cessation; MDA Appointment

February 4, 1994

In Brief: James Downing named CEO of St. Jude

June 27, 2014

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002